The Safety and Efficacy of SCTA01 Against COVID-19 in Patients Admitted to High Dependence or Intensive Care
Clinical trial NCT04683328 · UNKNOWN
Trial details
- NCT number
- NCT04683328
- Sponsor
- Sinocelltech Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-25
- Primary completion
- 2021-05-25
- Enrollment
- 560
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.